{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:33:15Z","timestamp":1761708795667},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.amjcard.2012.08.033","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T17:49:16Z","timestamp":1349977756000},"page":"43B-49B","source":"Crossref","is-referenced-by-count":25,"special_numbering":"S","title":["Cardiovascular Risk Factors in a Patient with Diabetes Mellitus and Coronary Artery Disease: Therapeutic Approaches to Improve Outcomes: Perspectives of a Preventive Cardiologist"],"prefix":"10.1016","volume":"110","author":[{"given":"Michael H.","family":"Davidson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.amjcard.2012.08.033_bib2","first-page":"S11","article-title":"Standards of medical care in diabetes\u20142011","volume":"34","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2012.08.033_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.08.033_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"issue":"suppl1","key":"10.1016\/j.amjcard.2012.08.033_bib5","first-page":"A762-P","article-title":"Meta-analysis demonstrates that liraglutide, a once-daily human GLP-1 analogue, significantly reduces lipids and other markers of cardiovascular risk in type 2 diabetes","volume":"52","author":"Plutzky","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.amjcard.2012.08.033_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"DeFronzo","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.08.033_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/diacare.27.1.41","article-title":"Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes","volume":"27","author":"Lawrence","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2012.08.033_bib8","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1001\/archinte.164.19.2097","article-title":"A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors","volume":"164","author":"Chiquette","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2012.08.033_bib9","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1001\/jama.296.21.joc60158","article-title":"Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes","volume":"296","author":"Mazzone","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2012.08.033_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jacc.2010.06.055","volume":"57","author":"Nicholls","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.08.033_bib11","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/diacare.27.7.1647","article-title":"The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive): can pioglitazone reduce cardiovascular events in diabetes?","volume":"27","author":"Charbonnel","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2012.08.033_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12325-011-0088-z","article-title":"DPP-4 inhibitors and lipids: systematic review and meta-analysis","volume":"29","author":"Monami","year":"2012","journal-title":"Adv Ther"},{"key":"10.1016\/j.amjcard.2012.08.033_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1463-1326.2011.01362.x","article-title":"Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes","volume":"4","author":"Tremblay","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.amjcard.2012.08.033_bib14","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00125-006-0340-2","article-title":"Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes","volume":"49","author":"Matikainen","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.amjcard.2012.08.033_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2010.05.028","article-title":"Exanatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus","volume":"212","author":"Schwartz","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2012.08.033_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","article-title":"Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26 week randomized, parallel-group, multinational, open-label trial (LEAD-6)","volume":"374","author":"Buse","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.08.033_bib17","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2012.08.033_bib18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.amjmed.2011.02.012","article-title":"Barriers to non-HDL cholesterol goal attainment by providers","volume":"124","author":"Virani","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2012.08.033_bib19","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","article-title":"VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.08.033_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2337\/db06-0935","article-title":"Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes","volume":"56","author":"Mazzone","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.amjcard.2012.08.033_bib21","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia","volume":"317","author":"Frick","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.08.033_bib22","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2012.08.033_bib23","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2012.08.033_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2012.08.033_bib25","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2012.08.033_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clinthera.2011.04.006","article-title":"Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes","volume":"33","author":"Ovalle","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2012.08.033_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.abb.2008.08.001","article-title":"GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP","volume":"478","author":"Green","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.amjcard.2012.08.033_bib28","doi-asserted-by":"crossref","first-page":"F355","DOI":"10.1152\/ajprenal.00729.2010","article-title":"Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1","volume":"301","author":"Crajoinas","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.amjcard.2012.08.033_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3810\/pgm.2010.05.2138","article-title":"A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes","volume":"122","author":"Frederich","year":"2010","journal-title":"Postgrad Med"},{"key":"10.1016\/j.amjcard.2012.08.033_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1185\/03007995.2011.602964","article-title":"Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials","volume":"27","author":"Monami","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjcard.2012.08.033_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1479164111408937","article-title":"Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2: 3 liraglutide clinical development studies","volume":"8","author":"Marso","year":"2011","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.amjcard.2012.08.033_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2337\/dc10-1393","article-title":"Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the GLP-1 receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLinkTM database","volume":"34","author":"Best","year":"2011","journal-title":"Diabetes Care"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912019984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912019984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T06:56:11Z","timestamp":1542696971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914912019984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0002914912019984"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.08.033","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}